[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Endocrine Peptides Test Market Size, Status and Forecast 2020-2026

May 2020 | 99 pages | ID: G21B22B15187EN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report focuses on the global Endocrine Peptides Test status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Endocrine Peptides Test development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
  • Quest Diagnostics
  • Siemens Healthcare
  • Abbott Laboratories
  • bioMerieux
  • ...
Market segment by Type, the product can be split into
  • Estradiol (E2)
  • Dehydroepiandrosterone Sulfate (DHEAS)
  • Human Chorionic Gonadotropin (hCG)
  • Progesterone, Luteinizing Hormone (LH)
  • Thyroid Stimulating Hormone (TSH)
  • Thyroid Prolactin
  • Others
Market segment by Application, split into
  • Hospitals
  • Physicians’ offices
  • Commercial Laboratories
  • Health Care Centers
Market segment by Regions/Countries, this report covers
  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
  • Central & South America
The study objectives of this report are:
  • To analyze global Endocrine Peptides Test status, future forecast, growth opportunity, key market and key players.
  • To present the Endocrine Peptides Test development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
  • To strategically profile the key players and comprehensively analyze their development plan and strategies.
  • To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Endocrine Peptides Test are as follows:
  • History Year: 2015-2019
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Endocrine Peptides Test Revenue
1.4 Market Analysis by Type
  1.4.1 Global Endocrine Peptides Test Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Estradiol (E2)
  1.4.3 Dehydroepiandrosterone Sulfate (DHEAS)
  1.4.4 Human Chorionic Gonadotropin (hCG)
  1.4.5 Progesterone, Luteinizing Hormone (LH)
  1.4.6 Thyroid Stimulating Hormone (TSH)
  1.4.7 Thyroid Prolactin
  1.4.8 Others
1.5 Market by Application
  1.5.1 Global Endocrine Peptides Test Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Physicians’ offices
  1.5.4 Commercial Laboratories
  1.5.5 Health Care Centers
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Endocrine Peptides Test Market Perspective (2015-2026)
2.2 Endocrine Peptides Test Growth Trends by Regions
  2.2.1 Endocrine Peptides Test Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Endocrine Peptides Test Historic Market Share by Regions (2015-2020)
  2.2.3 Endocrine Peptides Test Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Endocrine Peptides Test Market Growth Strategy
  2.3.6 Primary Interviews with Key Endocrine Peptides Test Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Endocrine Peptides Test Players by Market Size
  3.1.1 Global Top Endocrine Peptides Test Players by Revenue (2015-2020)
  3.1.2 Global Endocrine Peptides Test Revenue Market Share by Players (2015-2020)
  3.1.3 Global Endocrine Peptides Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Endocrine Peptides Test Market Concentration Ratio
  3.2.1 Global Endocrine Peptides Test Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Endocrine Peptides Test Revenue in 2019
3.3 Endocrine Peptides Test Key Players Head office and Area Served
3.4 Key Players Endocrine Peptides Test Product Solution and Service
3.5 Date of Enter into Endocrine Peptides Test Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Endocrine Peptides Test Historic Market Size by Type (2015-2020)
4.2 Global Endocrine Peptides Test Forecasted Market Size by Type (2021-2026)

5 ENDOCRINE PEPTIDES TEST BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Endocrine Peptides Test Market Size by Application (2015-2020)
5.2 Global Endocrine Peptides Test Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Endocrine Peptides Test Market Size (2015-2020)
6.2 Endocrine Peptides Test Key Players in North America (2019-2020)
6.3 North America Endocrine Peptides Test Market Size by Type (2015-2020)
6.4 North America Endocrine Peptides Test Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Endocrine Peptides Test Market Size (2015-2020)
7.2 Endocrine Peptides Test Key Players in Europe (2019-2020)
7.3 Europe Endocrine Peptides Test Market Size by Type (2015-2020)
7.4 Europe Endocrine Peptides Test Market Size by Application (2015-2020)

8 CHINA

8.1 China Endocrine Peptides Test Market Size (2015-2020)
8.2 Endocrine Peptides Test Key Players in China (2019-2020)
8.3 China Endocrine Peptides Test Market Size by Type (2015-2020)
8.4 China Endocrine Peptides Test Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Endocrine Peptides Test Market Size (2015-2020)
9.2 Endocrine Peptides Test Key Players in Japan (2019-2020)
9.3 Japan Endocrine Peptides Test Market Size by Type (2015-2020)
9.4 Japan Endocrine Peptides Test Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Endocrine Peptides Test Market Size (2015-2020)
10.2 Endocrine Peptides Test Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Endocrine Peptides Test Market Size by Type (2015-2020)
10.4 Southeast Asia Endocrine Peptides Test Market Size by Application (2015-2020)

11 INDIA

11.1 India Endocrine Peptides Test Market Size (2015-2020)
11.2 Endocrine Peptides Test Key Players in India (2019-2020)
11.3 India Endocrine Peptides Test Market Size by Type (2015-2020)
11.4 India Endocrine Peptides Test Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Endocrine Peptides Test Market Size (2015-2020)
12.2 Endocrine Peptides Test Key Players in Central & South America (2019-2020)
12.3 Central & South America Endocrine Peptides Test Market Size by Type (2015-2020)
12.4 Central & South America Endocrine Peptides Test Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Quest Diagnostics
  13.1.1 Quest Diagnostics Company Details
  13.1.2 Quest Diagnostics Business Overview and Its Total Revenue
  13.1.3 Quest Diagnostics Endocrine Peptides Test Introduction
  13.1.4 Quest Diagnostics Revenue in Endocrine Peptides Test Business (2015-2020))
  13.1.5 Quest Diagnostics Recent Development
13.2 Siemens Healthcare
  13.2.1 Siemens Healthcare Company Details
  13.2.2 Siemens Healthcare Business Overview and Its Total Revenue
  13.2.3 Siemens Healthcare Endocrine Peptides Test Introduction
  13.2.4 Siemens Healthcare Revenue in Endocrine Peptides Test Business (2015-2020)
  13.2.5 Siemens Healthcare Recent Development
13.3 Abbott Laboratories
  13.3.1 Abbott Laboratories Company Details
  13.3.2 Abbott Laboratories Business Overview and Its Total Revenue
  13.3.3 Abbott Laboratories Endocrine Peptides Test Introduction
  13.3.4 Abbott Laboratories Revenue in Endocrine Peptides Test Business (2015-2020)
  13.3.5 Abbott Laboratories Recent Development
13.4 bioMerieux
  13.4.1 bioMerieux Company Details
  13.4.2 bioMerieux Business Overview and Its Total Revenue
  13.4.3 bioMerieux Endocrine Peptides Test Introduction
  13.4.4 bioMerieux Revenue in Endocrine Peptides Test Business (2015-2020)
  13.4.5 bioMerieux Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES

Table 1. Endocrine Peptides Test Key Market Segments
Table 2. Key Players Covered: Ranking by Endocrine Peptides Test Revenue
Table 3. Ranking of Global Top Endocrine Peptides Test Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Endocrine Peptides Test Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Estradiol (E2)
Table 6. Key Players of Dehydroepiandrosterone Sulfate (DHEAS)
Table 7. Key Players of Human Chorionic Gonadotropin (hCG)
Table 8. Key Players of Progesterone, Luteinizing Hormone (LH)
Table 9. Key Players of Thyroid Stimulating Hormone (TSH)
Table 10. Key Players of Thyroid Prolactin
Table 11. Key Players of Others
Table 12. Global Endocrine Peptides Test Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Endocrine Peptides Test Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Endocrine Peptides Test Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Endocrine Peptides Test Market Share by Regions (2015-2020)
Table 16. Global Endocrine Peptides Test Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Endocrine Peptides Test Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Endocrine Peptides Test Market Growth Strategy
Table 22. Main Points Interviewed from Key Endocrine Peptides Test Players
Table 23. Global Endocrine Peptides Test Revenue by Players (2015-2020) (Million US$)
Table 24. Global Endocrine Peptides Test Market Share by Players (2015-2020)
Table 25. Global Top Endocrine Peptides Test Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Endocrine Peptides Test as of 2019)
Table 26. Global Endocrine Peptides Test by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Endocrine Peptides Test Product Solution and Service
Table 29. Date of Enter into Endocrine Peptides Test Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Endocrine Peptides Test Market Size by Type (2015-2020) (Million US$)
Table 32. Global Endocrine Peptides Test Market Size Share by Type (2015-2020)
Table 33. Global Endocrine Peptides Test Revenue Market Share by Type (2021-2026)
Table 34. Global Endocrine Peptides Test Market Size Share by Application (2015-2020)
Table 35. Global Endocrine Peptides Test Market Size by Application (2015-2020) (Million US$)
Table 36. Global Endocrine Peptides Test Market Size Share by Application (2021-2026)
Table 37. North America Key Players Endocrine Peptides Test Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Endocrine Peptides Test Market Share (2019-2020)
Table 39. North America Endocrine Peptides Test Market Size by Type (2015-2020) (Million US$)
Table 40. North America Endocrine Peptides Test Market Share by Type (2015-2020)
Table 41. North America Endocrine Peptides Test Market Size by Application (2015-2020) (Million US$)
Table 42. North America Endocrine Peptides Test Market Share by Application (2015-2020)
Table 43. Europe Key Players Endocrine Peptides Test Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Endocrine Peptides Test Market Share (2019-2020)
Table 45. Europe Endocrine Peptides Test Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Endocrine Peptides Test Market Share by Type (2015-2020)
Table 47. Europe Endocrine Peptides Test Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Endocrine Peptides Test Market Share by Application (2015-2020)
Table 49. China Key Players Endocrine Peptides Test Revenue (2019-2020) (Million US$)
Table 50. China Key Players Endocrine Peptides Test Market Share (2019-2020)
Table 51. China Endocrine Peptides Test Market Size by Type (2015-2020) (Million US$)
Table 52. China Endocrine Peptides Test Market Share by Type (2015-2020)
Table 53. China Endocrine Peptides Test Market Size by Application (2015-2020) (Million US$)
Table 54. China Endocrine Peptides Test Market Share by Application (2015-2020)
Table 55. Japan Key Players Endocrine Peptides Test Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Endocrine Peptides Test Market Share (2019-2020)
Table 57. Japan Endocrine Peptides Test Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Endocrine Peptides Test Market Share by Type (2015-2020)
Table 59. Japan Endocrine Peptides Test Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Endocrine Peptides Test Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Endocrine Peptides Test Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Endocrine Peptides Test Market Share (2019-2020)
Table 63. Southeast Asia Endocrine Peptides Test Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Endocrine Peptides Test Market Share by Type (2015-2020)
Table 65. Southeast Asia Endocrine Peptides Test Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Endocrine Peptides Test Market Share by Application (2015-2020)
Table 67. India Key Players Endocrine Peptides Test Revenue (2019-2020) (Million US$)
Table 68. India Key Players Endocrine Peptides Test Market Share (2019-2020)
Table 69. India Endocrine Peptides Test Market Size by Type (2015-2020) (Million US$)
Table 70. India Endocrine Peptides Test Market Share by Type (2015-2020)
Table 71. India Endocrine Peptides Test Market Size by Application (2015-2020) (Million US$)
Table 72. India Endocrine Peptides Test Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Endocrine Peptides Test Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Endocrine Peptides Test Market Share (2019-2020)
Table 75. Central & South America Endocrine Peptides Test Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Endocrine Peptides Test Market Share by Type (2015-2020)
Table 77. Central & South America Endocrine Peptides Test Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Endocrine Peptides Test Market Share by Application (2015-2020)
Table 79. Quest Diagnostics Company Details
Table 80. Quest Diagnostics Business Overview
Table 81. Quest Diagnostics Product
Table 82. Quest Diagnostics Revenue in Endocrine Peptides Test Business (2015-2020) (Million US$)
Table 83. Quest Diagnostics Recent Development
Table 84. Siemens Healthcare Company Details
Table 85. Siemens Healthcare Business Overview
Table 86. Siemens Healthcare Product
Table 87. Siemens Healthcare Revenue in Endocrine Peptides Test Business (2015-2020) (Million US$)
Table 88. Siemens Healthcare Recent Development
Table 89. Abbott Laboratories Company Details
Table 90. Abbott Laboratories Business Overview
Table 91. Abbott Laboratories Product
Table 92. Abbott Laboratories Revenue in Endocrine Peptides Test Business (2015-2020) (Million US$)
Table 93. Abbott Laboratories Recent Development
Table 94. bioMerieux Company Details
Table 95. bioMerieux Business Overview
Table 96. bioMerieux Product
Table 97. bioMerieux Revenue in Endocrine Peptides Test Business (2015-2020) (Million US$)
Table 98. bioMerieux Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Global Endocrine Peptides Test Market Share by Type: 2020 VS 2026
Figure 2. Estradiol (E2) Features
Figure 3. Dehydroepiandrosterone Sulfate (DHEAS) Features
Figure 4. Human Chorionic Gonadotropin (hCG) Features
Figure 5. Progesterone, Luteinizing Hormone (LH) Features
Figure 6. Thyroid Stimulating Hormone (TSH) Features
Figure 7. Thyroid Prolactin Features
Figure 8. Others Features
Figure 9. Global Endocrine Peptides Test Market Share by Application: 2020 VS 2026
Figure 10. Hospitals Case Studies
Figure 11. Physicians’ offices Case Studies
Figure 12. Commercial Laboratories Case Studies
Figure 13. Health Care Centers Case Studies
Figure 14. Endocrine Peptides Test Report Years Considered
Figure 15. Global Endocrine Peptides Test Market Size YoY Growth 2015-2026 (US$ Million)
Figure 16. Global Endocrine Peptides Test Market Share by Regions: 2020 VS 2026
Figure 17. Global Endocrine Peptides Test Market Share by Regions (2021-2026)
Figure 18. Porter's Five Forces Analysis
Figure 19. Global Endocrine Peptides Test Market Share by Players in 2019
Figure 20. Global Top Endocrine Peptides Test Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Endocrine Peptides Test as of 2019
Figure 21. The Top 10 and 5 Players Market Share by Endocrine Peptides Test Revenue in 2019
Figure 22. North America Endocrine Peptides Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Europe Endocrine Peptides Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. China Endocrine Peptides Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Japan Endocrine Peptides Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Southeast Asia Endocrine Peptides Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. India Endocrine Peptides Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Central & South America Endocrine Peptides Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Quest Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Quest Diagnostics Revenue Growth Rate in Endocrine Peptides Test Business (2015-2020)
Figure 31. Siemens Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Siemens Healthcare Revenue Growth Rate in Endocrine Peptides Test Business (2015-2020)
Figure 33. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Abbott Laboratories Revenue Growth Rate in Endocrine Peptides Test Business (2015-2020)
Figure 35. bioMerieux Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. bioMerieux Revenue Growth Rate in Endocrine Peptides Test Business (2015-2020)
Figure 37. Bottom-up and Top-down Approaches for This Report
Figure 38. Data Triangulation
Figure 39. Key Executives Interviewed


More Publications